| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07169552 | HC010 in First-line PD-L1 Positive Advanced NSCLC Patients | NSCLC | Recruiting |
| Phase 1 | |||
| NCT06657703 | Safety, Tolerability, and Pharmacokinetics of Single Doses of HC022 in Healthy Subjects. | Systemic Lupus Erythematosus | Recruiting |
| NCT06304571 | A Study of HC006 in Subjects With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting |
| NCT06307925 | A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010… | Advanced Solid Tumor | Recruiting |
| NCT06963814 | Study of HC006 in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumors | Advanced Cancer | Recruiting |
| NCT07381829 | A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy… | Advanced Solid Tumor Cancer | Recruiting |
| NCT07477743 | A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced… | Advanced Solid Tumor Cancer | Recruiting |
| NCT07306585 | The Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of… | Systemic Lupus Erythematosus (SLE) | Not Yet Recruiting |